JP2022523553A5 - - Google Patents
Info
- Publication number
- JP2022523553A5 JP2022523553A5 JP2021552599A JP2021552599A JP2022523553A5 JP 2022523553 A5 JP2022523553 A5 JP 2022523553A5 JP 2021552599 A JP2021552599 A JP 2021552599A JP 2021552599 A JP2021552599 A JP 2021552599A JP 2022523553 A5 JP2022523553 A5 JP 2022523553A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tcr
- eso
- acid sequence
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813644P | 2019-03-04 | 2019-03-04 | |
| US62/813,644 | 2019-03-04 | ||
| PCT/IB2020/051809 WO2020178740A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523553A JP2022523553A (ja) | 2022-04-25 |
| JP2022523553A5 true JP2022523553A5 (cg-RX-API-DMAC7.html) | 2023-03-13 |
| JP7748284B2 JP7748284B2 (ja) | 2025-10-02 |
Family
ID=72337471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552599A Active JP7748284B2 (ja) | 2019-03-04 | 2020-03-03 | T細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12527809B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3935175A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7748284B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210149049A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113795583B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020231693A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021017491A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3132242A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL286039A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021010542A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202109590VA (cg-RX-API-DMAC7.html) |
| TW (1) | TW202100547A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020178740A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021010537A (es) | 2019-03-04 | 2021-12-10 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| AU2020231927A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| US12522644B2 (en) | 2019-03-04 | 2026-01-13 | University Health Network | T cell receptors and methods of use thereof |
| AU2020231693A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| CA3133945A1 (en) | 2019-03-25 | 2020-10-01 | University Health Network | T cell receptors and methods of use thereof |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2323632A1 (en) | 1998-03-13 | 1999-09-16 | Epimmune Inc. | Hla-binding peptides and their uses |
| CA2388301C (en) | 1999-10-22 | 2011-01-04 | Aventis Pasteur Limited | Modified gp100 and uses thereof |
| CA2682093A1 (en) | 2007-03-29 | 2008-10-09 | Technion Research & Development Foundation Ltd. | Antibodies, methods and kits for diagnosing and treating melanoma |
| EP3031916B1 (en) | 2007-06-11 | 2017-06-07 | Takara Bio Inc. | Method for expression of specific gene |
| WO2010037395A2 (en) | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| WO2010112962A1 (en) | 2009-04-02 | 2010-10-07 | Vaxon Biotech | Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy |
| US9314516B2 (en) * | 2010-05-04 | 2016-04-19 | Cassian Yee | Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses |
| ES2635335T3 (es) | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CN105555756B (zh) | 2013-06-28 | 2018-12-07 | 奥克兰联合服务有限公司 | 氨基酸缀合物和肽缀合物及缀合方法 |
| KR101503341B1 (ko) | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
| ES2924709T3 (es) | 2014-10-02 | 2022-10-10 | Us Health | Métodos de aislamiento de receptores de células T que tienen especificidad antigénica para una mutación específica de cáncer |
| CA2964785A1 (en) | 2014-11-05 | 2016-05-12 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| EP3067366A1 (en) | 2015-03-13 | 2016-09-14 | Max-Delbrück-Centrum Für Molekulare Medizin | Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1 |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| CN106632658B (zh) * | 2015-11-04 | 2020-10-27 | 广东香雪精准医疗技术有限公司 | 识别ny-eso-1抗原短肽的tcr |
| JP6895975B2 (ja) | 2016-01-06 | 2021-06-30 | ヘルス リサーチ インコーポレイテッドHealth Research, Inc. | 組換えt細胞受容体を含む組成物及びライブラリー並びに組換えt細胞受容体を使用する方法 |
| JP2019521080A (ja) | 2016-04-27 | 2019-07-25 | ユニバーシティ・ヘルス・ネットワーク | ペプチド−hla複合体およびその産生方法 |
| AU2017356322B2 (en) * | 2016-11-14 | 2023-09-21 | Fred Hutchinson Cancer Center | High affinity merkel cell polyomavirus T antigen-specific TCRs and uses thereof |
| JP7289028B2 (ja) * | 2018-09-05 | 2023-06-09 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 複数の主要組織適合遺伝子複合体分子に制限したny-eso-1-特異的t細胞受容体の組成物 |
| AU2020231927A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| BR112021017404A2 (pt) | 2019-03-04 | 2022-02-01 | Univ Health Network | Receptores de células t e métodos de uso dos mesmos |
| MX2021010537A (es) | 2019-03-04 | 2021-12-10 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| EP3935173A4 (en) | 2019-03-04 | 2023-05-31 | University Health Network | T-CELL RECEPTORS AND METHODS OF USE THEREOF |
| AU2020231693A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| CA3132434A1 (en) | 2019-03-04 | 2020-09-10 | University Health Network | T cell receptors and methods of use thereof |
| US12522644B2 (en) | 2019-03-04 | 2026-01-13 | University Health Network | T cell receptors and methods of use thereof |
| CA3133945A1 (en) | 2019-03-25 | 2020-10-01 | University Health Network | T cell receptors and methods of use thereof |
| TW202116797A (zh) | 2019-07-30 | 2021-05-01 | 大學健康網絡 | Ii類mhc分子及其使用方法 |
| MX2022001206A (es) | 2019-07-30 | 2022-05-03 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
| AU2020320129A1 (en) | 2019-07-30 | 2022-03-03 | University Health Network | T cell receptors and methods of use thereof |
| KR20220052944A (ko) | 2019-07-30 | 2022-04-28 | 유니버시티 헬스 네트워크 | Mhc 클래스 ii 분자 및 이의 사용 방법 |
| TWI881991B (zh) | 2019-07-30 | 2025-05-01 | 大學健康網絡 | Ii類mhc分子及其使用方法 |
| US20220291215A1 (en) | 2019-07-30 | 2022-09-15 | University Health Network | Methods of identifying t cell receptors |
| WO2021019472A1 (en) | 2019-07-30 | 2021-02-04 | University Health Network | T cell receptors and methods of use thereof |
| WO2023076875A1 (en) * | 2021-10-25 | 2023-05-04 | The Regents Of The University Of California | Methods and compositions for treating glioblastoma |
-
2020
- 2020-03-03 AU AU2020231693A patent/AU2020231693A1/en active Pending
- 2020-03-03 WO PCT/IB2020/051809 patent/WO2020178740A1/en not_active Ceased
- 2020-03-03 CA CA3132242A patent/CA3132242A1/en active Pending
- 2020-03-03 KR KR1020217031569A patent/KR20210149049A/ko active Pending
- 2020-03-03 US US17/436,933 patent/US12527809B2/en active Active
- 2020-03-03 CN CN202080024940.8A patent/CN113795583B/zh active Active
- 2020-03-03 BR BR112021017491A patent/BR112021017491A2/pt not_active IP Right Cessation
- 2020-03-03 SG SG11202109590V patent/SG11202109590VA/en unknown
- 2020-03-03 EP EP20766869.0A patent/EP3935175A4/en active Pending
- 2020-03-03 JP JP2021552599A patent/JP7748284B2/ja active Active
- 2020-03-03 MX MX2021010542A patent/MX2021010542A/es unknown
- 2020-03-04 TW TW109107113A patent/TW202100547A/zh unknown
-
2021
- 2021-09-01 IL IL286039A patent/IL286039A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (cg-RX-API-DMAC7.html) | ||
| JP2022523552A5 (cg-RX-API-DMAC7.html) | ||
| JP2022524993A5 (cg-RX-API-DMAC7.html) | ||
| JP2022523971A5 (cg-RX-API-DMAC7.html) | ||
| JP2022524994A5 (cg-RX-API-DMAC7.html) | ||
| JP2022523554A5 (cg-RX-API-DMAC7.html) | ||
| JP2022524992A5 (cg-RX-API-DMAC7.html) | ||
| CN113286811B (zh) | 改善过继性细胞疗法的效力和安全性 | |
| Baxevanis et al. | Cancer immunotherapy | |
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| Kershaw et al. | Gene-engineered T cells for cancer therapy | |
| JP2022543059A5 (cg-RX-API-DMAC7.html) | ||
| US20200038443A1 (en) | Multi-function and multi-targeting car system and methods for use thereof | |
| Merhavi-Shoham et al. | Adoptive cell therapy for metastatic melanoma | |
| CN109694854B (zh) | 通用型嵌合抗原受体t细胞制备技术 | |
| JP2020509767A5 (cg-RX-API-DMAC7.html) | ||
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| Murad et al. | Advances in the use of natural receptor-or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies | |
| CN113785065B (zh) | T细胞受体及其使用方法 | |
| CN108138148A (zh) | T细胞的激活和扩增 | |
| CN107847585A (zh) | 用于得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| JP2022543060A5 (cg-RX-API-DMAC7.html) |